Rebuilding Clinical Trial Infrastructure: Dr. Nikola Cihoric on oomnia, Responsible AI & Wemedoo’s Unified Future
Dr. Nikola Cihoric — Founder & Senior Representative, Wemedoo AG
In this powerful Xraised interview, Dr. Nikola Cihoric, Founder and Member of the Board at Wemedoo AG, reveals how his company is reshaping the global clinical research landscape. After five years of development, 2025 marked a transformative moment for Wemedoo—with the company winning the SCDM Innovator Start-up of the Year Award and securing a partnership with Across Global Alliance, granting access to 16 CROs operating in more than 60 countries.
Dr. Cihoric explains that the industry has reached an inflection point. Legacy systems built decades ago cannot support today’s decentralized trials, multimodal data streams, and AI-driven workflows. Traditional platforms still rely on fragmented architectures—EDC from one acquisition, CTMS from another, and eTMF stitched together through APIs. The result is latency, data inconsistency, and operational inefficiency.
Comments
No comments yet — be the first to share your thoughts.